ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Sang Lin

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5103659595. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2025: 1 paper

Papers 1

Histone serotonylation promotes pancreatic cancer development via lipid metabolism remodeling. Co-author DOI 10.1038/s41467-025-61197-z ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Aziguli Tulamaiti · 1 shared paper, 2025 · strength 0.22
- Paper Histone serotonylation promotes pancreatic cancer development via lipid metabolism remodeling. DOI 10.1038/s41467-025-61197-z ↗
Xueli Zhang · 1 shared paper, 2025 · strength 0.22
- Paper Histone serotonylation promotes pancreatic cancer development via lipid metabolism remodeling. DOI 10.1038/s41467-025-61197-z ↗
Zhigang Zhang · 1 shared paper, 2025 · strength 0.22
- Paper Histone serotonylation promotes pancreatic cancer development via lipid metabolism remodeling. DOI 10.1038/s41467-025-61197-z ↗
Xiaodong Zhao · 1 shared paper, 2025 · strength 0.22
- Paper Histone serotonylation promotes pancreatic cancer development via lipid metabolism remodeling. DOI 10.1038/s41467-025-61197-z ↗
Hua Li · 1 shared paper, 2025 · strength 0.22
- Paper Histone serotonylation promotes pancreatic cancer development via lipid metabolism remodeling. DOI 10.1038/s41467-025-61197-z ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.